Neuromedin U receptor 2 agonists suppress cocaine self-administration in male rats
Rationale Cocaine use disorder (CUD) remains without an FDA-approved pharmacotherapy, highlighting the need for novel mechanistically distinct targets. Prior work implicates neuromedin U (NMU) and its receptor NMU receptor 2 (NMUR2) in cocaine-directed behavior, but NMUR2 peptide-based approaches have limited translati...